Works matching DE "VERTEPORFIN"

Results: 88

Photothrombosis of Corneal Neovascularization by Photodynamic Therapy Utilizing Verteporfin and Diode Laser.

Published in:

Journal of Lasers in Medical Sciences, 2013, v. 4, n. 3, p. 131

By:

Ahmed Hassan, Aziza;
Foad Ghoneim, Dina;
Adeiraheem El-dib, Amr;
Abdelkawi Ahmed, Saiwa;
Medhat Abdel- Salam, Ahmed

Publication type:

Article

Verteporfin, a suppressor of YAP-TEAD complex, presents promising antitumor properties on ovarian cancer.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 5371, doi. 10.2147/OTT.S109979

By:

Juntao Feng;
Jinhai Gou;
Jia Jia;
Tao Yi;
Tao Cui;
Zhengyu Li

Publication type:

Article

Transient Increased Exudation after Photodynamic Therapy of Intraocular Tumors.

Published in:

Middle East African Journal of Ophthalmology, 2013, v. 20, n. 1, p. 83, doi. 10.4103/0974-9233.106400

By:

Mashayekhi, Arman;
Shields, Carol L.;
Shields, Jerry A.

Publication type:

Article

A rodent model of anterior ischemic optic neuropathy (AION) based on laser photoactivation of verteporfin.

Published in:

2018

By:

Min, Jing-yu;
Lv, Yanan;
Mao, Lei;
Gong, Yuan-yuan;
Gu, Qing;
Wei, Fang

Publication type:

journal article

3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92693-z

By:

Hu, Yu-Chen;
Chen, Yi-Ling;
Chen, Yen-Chih;
Chen, San-Ni

Publication type:

Article

The impact of interaction between verteporfin and yes-associated protein 1/transcriptional coactivator with PDZ-binding motif-TEA domain pathway on the progression of isocitrate dehydrogenase wild-type glioblastoma.

Published in:

Journal of Central Nervous System Disease, 2023, p. 1, doi. 10.1177/11795735231195760

By:

Osama, Mahmoud;
Essibayi, Muhammed Amir;
Osama, Mona;
Ibrahim, Ismail A.;
Nasr Mostafa, Mostafa;
Şakir Ekşi, Murat

Publication type:

Article

Proteostasis trumps YAP in colon cancer.

Published in:

Science Signaling, 2015, v. 8, n. 397, p. 1, doi. 10.1126/scisignal.aad3123

By:

Avril, Tony;
Chevet, Eric

Publication type:

Article

Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1.

Published in:

Science Signaling, 2015, v. 8, n. 397, p. 1, doi. 10.1126/scisignal.aac5418

By:

Huabing Zhang;
Ramakrishnan, Sadeesh K.;
Triner, Daniel;
Centofanti, Brook;
Maitra, Dhiman;
Győrffy, Balázs;
Sebolt-Leopold, Judith S.;
Dame, Michael K.;
Varani, James;
Brenner, Dean E.;
Fearon, Eric R.;
Omary, M. Bishr;
Shah, Yatrik M.

Publication type:

Article

Efficacy of metformin and verteporfin treatment alone or in combination in a murine head and neck cancer xenograft model.

Published in:

European Journal of Oral Sciences, 2025, v. 133, n. 1, p. 1, doi. 10.1111/eos.13034

By:

Shan, Aung Phyo;
Hlaing, Khin Swe;
Leelahavanichkul, Asada;
Amornphimoltham, Panomwat

Publication type:

Article

Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin.

Published in:

PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114964

By:

Donohue, Elizabeth;
Balgi, Aruna D.;
Komatsu, Masaaki;
Roberge, Michel

Publication type:

Article

Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes.

Published in:

Eye (0950-222X), 2013, v. 27, n. 5, p. 612, doi. 10.1038/eye.2013.24

By:

Karakus, S H;
Basarir, B;
Pinarci, E Y;
Kirandi, E U;
Demirok, A

Publication type:

Article

Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy.

Published in:

Therapeutics & Clinical Risk Management, 2014, v. 10, p. 37, doi. 10.2147/TCRM.S54213

By:

Yalong Dang;
Xinfeng Sun;
Yongsheng Xu;
Yalin Mu;
Manli Zhao;
Jing Zhao;
Yu Zhu;
Chun Zhang

Publication type:

Article

Real-World Experience with Half-Time Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.

Published in:

2017

By:

Peng, Shu-Yen;
Lai, Chi-Chun;
Wang, Nan-Kai;
Wu, Wei-Chi;
Hwang, Yih-Shiou;
Chen, Kuan-Jen;
Chen, Lee-Jen;
Tsai, Shawn;
Chan, Wei-Chun;
Liu, Laura;
Yeung, Ling

Publication type:

journal article

Half-Dose Verteporfin Combined with Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.

Published in:

Journal of Ocular Pharmacology & Therapeutics, 2014, v. 30, n. 5, p. 400, doi. 10.1089/jop.2013.0169

By:

Liu, Chun-Fu;
Chen, Lee-Jen;
Tsai, Shawn H.;
Lai, Chi-Chun;
Chan, Wei-Chun;
Wu, Wei-Chi;
Wang, Nan-Kai;
Chen, Kuan-Jen;
Hwang, Yih-Shiou;
Chen, Yen-Po;
Yeung, Ling

Publication type:

Article

Rabbit model of ocular indirect photodynamic therapy using a retinoblastoma xenograft.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2017, v. 255, n. 12, p. 2363, doi. 10.1007/s00417-017-3805-8

By:

Kim, Jonathan;
Jacobsen, Bradley;
Zolfaghari, Emily;
Ferrario, Angela;
Chevez-Barrios, Patricia;
Berry, Jesse;
Lee, Diana;
Rico, Grecia;
Madi, Ingy;
Rao, Narsing;
Stachelek, Kevin;
Wang, Lei-chi;
Gomer, Charles

Publication type:

Article

Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2017, v. 255, n. 3, p. 529, doi. 10.1007/s00417-016-3498-4

By:

Rinaldi, M.;
Semeraro, F.;
Chiosi, F.;
Russo, A.;
Romano, M.;
Savastano, M.;
dell'Omo, R.;
Costagliola, C.

Publication type:

Article

One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2017, v. 255, n. 3, p. 541, doi. 10.1007/s00417-016-3500-1

By:

Matsumiya, Wataru;
Honda, Shigeru;
Otsuka, Keiko;
Miki, Akiko;
Nagai, Takayuki;
Imai, Hisanori;
Kusuhara, Sentaro;
Nakamura, Makoto

Publication type:

Article

The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2013, v. 251, n. 4, p. 1081, doi. 10.1007/s00417-012-2139-9

By:

Hagen, Stefan;
Ansari-Shahrezaei, Siamak;
Smretschnig, Eva;
Glittenberg, Carl;
Krebs, Ilse;
Graf, Alexandra;
Binder, Susanne

Publication type:

Article

Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.

Published in:

2013

By:

Mak, Shiu;
Wong, Albert

Publication type:

Letter

Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy.

Published in:

2013

By:

Arevalo, J.;
Espinoza, Juan

Publication type:

Letter

Research progress of hydroxychloroquine and autophagy inhibitors on cancer.

Published in:

2017

By:

Shi, Ting-Ting;
Yu, Xiao-Xu;
Yan, Li-Jun;
Xiao, Hong-Tao

Publication type:

journal article

Verteporfin can Reverse the Paclitaxel Resistance Induced by YAP Over-Expression in HCT-8/T Cells without Photoactivation through Inhibiting YAP Expression.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2016, v. 39, n. 2, p. 481, doi. 10.1159/000445640

By:

Pan, Wang;
Wang, Qian;
Zhang, Yi;
Zhang, Naishu;
Qin, Jiamin;
Li, Wei;
Wang, Jing;
Wu, Fangfang;
Cao, Lingsen;
Xu, Guanglin

Publication type:

Article

Wet AMD market.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 11, p. 827, doi. 10.1038/nrd3790

By:

Syed, Basharut A.;
Evans, James B.;
Bielory, Leonard

Publication type:

Article

Photodynamic therapy with verteporfin accelerates apoptotic bleb formation in human ameloblastoma.

Published in:

Oral Diseases, 2024, v. 30, n. 5, p. 3261, doi. 10.1111/odi.14775

By:

Yamashita, Junya;
Kimoto, Akira;
Teraoka, Shun;
Hiraoka, Yujiro;
Takeda, Daisuke;
Kakei, Yasumasa;
Shigeoka, Manabu;
Hasegawa, Takumi;
Akashi, Masaya

Publication type:

Article

Current Therapeutic Approaches to Chronic Central Serous Chorioretinopathy.

Published in:

Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi, 2019, v. 49, n. 1, p. 30, doi. 10.4274/tjo.galenos.2018.49035

By:

Gülkaş, Samet;
Şahin, Özlem

Publication type:

Article

Photodynamic Therapy for Diffuse Choroidal Hemangioma in Sturge-Weber Syndrome.

Published in:

2014

By:

Monteiro, Sílvia;
Casal, Inês;
Santos, Marinho;
Meireles, Angelina

Publication type:

Case Study

Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup.

Published in:

Case Reports in Medicine, 2012, p. 1, doi. 10.1155/2012/897097

By:

Fernández, Maribel;
Gil, María;
Gomez-Ulla, Francisco;
Charlón, Pablo

Publication type:

Article

In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.

Published in:

Journal of Mammary Gland Biology & Neoplasia, 2017, v. 22, n. 3, p. 203, doi. 10.1007/s10911-017-9384-9

By:

Guillemette, Samantha;
Rico, Charlène;
Godin, Philippe;
Boerboom, Derek;
Paquet, Marilène

Publication type:

Article

连翘苷通过激活Hippo-YAP信号通路抑制结肠癌LS180 细胞的恶性生物学行为.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 6, p. 566, doi. 10.3872/j.issn.1007-385x.2024.06.004

By:

郑成富;
周贵丰;
李青;
陈营

Publication type:

Article

Ranibizumab plus Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration: 12 Months of Retreatment and Vision Outcomes from a Randomized Study.

Published in:

Ophthalmologica, 2015, v. 233, n. 2, p. 66, doi. 10.1159/000367603

By:

Hatz, Katja;
Schneider, Ulrike;
Henrich, P. Bernhard;
Braun, Beatrice;
Sacu, Stefan;
Prünte, Christian

Publication type:

Article

Cost and Effectiveness of Therapy for Wet Age-Related Macular Degeneration in Routine Clinical Practice.

Published in:

Ophthalmologica, 2013, v. 230, n. 1, p. 34, doi. 10.1159/000350802

By:

Studnička, Jan;
Říhová, Barbora;
Rencová, Eva;
Rozsíval, Pavel;
Dubská, Zora;
Chrapek, Oldřich;
Kolář, Petr;
Kandrnal, Vít;
Demlová, Regina;
Pitrová, Šárka;
Řehák, Jiří

Publication type:

Article

Photodynamic Therapy Combined with Intravitreal Bevacizumab (Avastin) in Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.

Published in:

Collegium Antropologicum, 2007, v. 31, n. s1, p. 71

By:

Lazić, Ratimir;
Gabrić, Nikica;
Dekaris, Iva;
Gavrić, Morena;
Bosnar, Damir

Publication type:

Article

Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma.

Published in:

Cancers, 2023, v. 15, n. 9, p. 2454, doi. 10.3390/cancers15092454

By:

Golino, Jihye L.;
Wang, Xin;
Bian, Jing;
Ruf, Benjamin;
Kelly, Michael;
Karim, Baktiar O.;
Cam, Maggie C.;
Xie, Changqing

Publication type:

Article

A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin.

Published in:

Cancers, 2023, v. 15, n. 4, p. 1085, doi. 10.3390/cancers15041085

By:

Liang, Jiyong;
Fang, Dexing;
Gumin, Joy;
Najem, Hinda;
Sooreshjani, Moloud;
Song, Renduo;
Sabbagh, Aria;
Kong, Ling-Yuan;
Duffy, Joseph;
Balyasnikova, Irina V.;
Pollack, Seth M.;
Puduvalli, Vinay K.;
Heimberger, Amy B.

Publication type:

Article

Hippo in Gastric Cancer: From Signalling to Therapy.

Published in:

Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092282

By:

Seeneevassen, Lornella;
Dubus, Pierre;
Gronnier, Caroline;
Varon, Christine

Publication type:

Article

Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma.

Published in:

Cancers, 2022, v. 14, n. 4, p. 923, doi. 10.3390/cancers14040923

By:

Quinet, Grégoire;
Xolalpa, Wendy;
Reyes-Garau, Diana;
Profitós-Pelejà, Núria;
Azkargorta, Mikel;
Ceccato, Laurie;
Gonzalez-Santamarta, Maria;
Marsal, Maria;
Andilla, Jordi;
Aillet, Fabienne;
Bosch, Francesc;
Elortza, Felix;
Loza-Alvarez, Pablo;
Sola, Brigitte;
Coux, Olivier;
Matthiesen, Rune;
Roué, Gaël;
Rodriguez, Manuel S.

Publication type:

Article

YAP1 Is a Potential Predictive Molecular Biomarker for Response to SMO Inhibitor in Medulloblastoma Cells.

Published in:

Cancers, 2021, v. 13, n. 24, p. 6249, doi. 10.3390/cancers13246249

By:

Alencastro Veiga Cruzeiro, Gustavo;
de Almeida Magalhães, Taciani;
Ribeiro de Sousa, Graziella;
Bonfim Silva, Ricardo;
Alberto Oliveira de Biagi Junior, Carlos;
Ferreira das Chagas, Pablo;
Gomes de Paula Queiroz, Rosane;
Alberto Scrideli, Carlos;
Gonzaga Tone, Luiz;
Terci Valera, Elvis

Publication type:

Article

Dramatic Reduction of Distant Pancreatic Metastases Using Local Light Activation of Verteporfin with Nab-Paclitaxel.

Published in:

Cancers, 2021, v. 13, n. 22, p. 5781, doi. 10.3390/cancers13225781

By:

Pigula, Michael;
Mai, Zhiming;
Anbil, Sriram;
Choi, Myung-Gyu;
Wang, Kenneth;
Maytin, Edward;
Pogue, Brian;
Hasan, Tayyaba

Publication type:

Article

Photodynamic Priming Improves the Anti-Migratory Activity of Prostaglandin E Receptor 4 Antagonist in Cancer Cells In Vitro.

Published in:

Cancers, 2021, v. 13, n. 21, p. 5259, doi. 10.3390/cancers13215259

By:

Sorrin, Aaron J.;
Liu, Cindy;
Cicalo, Julia;
Reader, Jocelyn;
Najafali, Daniel;
Zhang, Yuji;
Roque, Dana M.;
Huang, Huang-Chiao

Publication type:

Article

Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas.

Published in:

Cancers, 2021, v. 13, n. 4, p. 675, doi. 10.3390/cancers13040675

By:

Rytlewski, Jeffrey D.;
Scalora, Nicholas;
Garcia, Keith;
Tanas, Munir;
Toor, Fatima;
Miller, Benjamin;
Allen, Bryan;
Milhem, Mohammed;
Monga, Varun;
van Houdt, Winan J.;
Kasper, Bernd;
Beier, Justus P.

Publication type:

Article

The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth.

Published in:

Cancers, 2020, v. 12, n. 12, p. 3847, doi. 10.3390/cancers12123847

By:

Morice, Sarah;
Mullard, Mathilde;
Brion, Regis;
Dupuy, Maryne;
Renault, Sarah;
Tesfaye, Robel;
Brounais-Le Royer, Bénédicte;
Ory, Benjamin;
Redini, Françoise;
Verrecchia, Franck

Publication type:

Article

The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing.

Published in:

Cancers, 2020, v. 12, n. 9, p. 2717, doi. 10.3390/cancers12092717

By:

Zawacka-Pankau, Joanna E.

Publication type:

Article

Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer.

Published in:

Cancers, 2020, v. 12, n. 4, p. 778, doi. 10.3390/cancers12040778

By:

García, Patricia;
Rosa, Lorena;
Vargas, Sergio;
Weber, Helga;
Espinoza, Jaime A.;
Suárez, Felipe;
Romero-Calvo, Isabel;
Elgueta, Nicole;
Rivera, Vanessa;
Nervi, Bruno;
Obreque, Javiera;
Leal, Pamela;
Viñuela, Eduardo;
Aguayo, Gloria;
Muñiz, Sabrina;
Sagredo, Alfredo;
Roa, Juan C.;
Bizama, Carolina

Publication type:

Article

Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo.

Published in:

Cancers, 2019, v. 11, n. 11, p. 1760, doi. 10.3390/cancers11111760

By:

Michy, Thierry;
Massias, Thibault;
Bernard, Claire;
Vanwonterghem, Laetitia;
Henry, Maxime;
Guidetti, Mélanie;
Royal, Guy;
Coll, Jean-Luc;
Texier, Isabelle;
Josserand, Véronique;
Hurbin, Amandine

Publication type:

Article

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study.

Published in:

Clinical Ophthalmology, 2018, v. 12, p. 1789, doi. 10.2147/OPTH.S171015

By:

Takahashi, Kanji;
Ohji, Masahito;
Terasaki, Hiroko;
Honda, Shigeru;
Margaron, Philippe;
Guerin, Tadhg;
Yuzawa, Mitsuko

Publication type:

Article

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy.

Published in:

Clinical Ophthalmology, 2017, v. 11, p. 2145, doi. 10.2147/OPTH.S151933

By:

Dhirani, Nadeem Ali;
Yelin Yang;
Somani, Sohel

Publication type:

Article

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial.

Published in:

Clinical Ophthalmology, 2017, v. 11, p. 223, doi. 10.2147/OPTH.S119510

By:

Gallemore, Ron P.;
Wallsh, Josh;
Hudson, Henry L.;
Ho, Allen C.;
Chace, Richard;
Pearlman, Joel

Publication type:

Article

Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation.

Published in:

Clinical Ophthalmology, 2016, v. 10, p. 861, doi. 10.2147/OPTH.S106092

By:

Arias, Luis;
Gómez-Ulla, Francisco;
Ruiz-Moreno, José M.

Publication type:

Article

Current and emerging treatment options for myopic choroidal neovascularization.

Published in:

Clinical Ophthalmology, 2015, v. 9, p. 733, doi. 10.2147/OPTH.S49437

By:

El Matri, Leila;
Chebil, Ahmed;
Kort, Fedra

Publication type:

Article

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.

Published in:

Clinical Ophthalmology, 2014, v. 8, p. 685, doi. 10.2147/OPTH.S58617

By:

Alkin, Zeynep;
Perente, Irfan;
Ozkaya, Abdullah;
Alp, Dilek;
Agca, Alper;
Demet Aygit, Ebru;
Korkmaz, Selcuk;
Taylan Yazici, Ahmet;
Demirok, Ahmet

Publication type:

Article